1. Aluminium may not be safe at any dose

   Newsletter Article 31 January 2013 Pages: 1 - 1

2. Parenteral administration reduces the risks of estrogen therapy

   Newsletter Article 31 January 2013 Pages: 1 - 1

3. Hypoprothrombinaemia complicates antibacterial therapy

   Newsletter Article 31 January 2013 Pages: 2 - 3

4. Acetylcysteine

   Newsletter Article 31 January 2013 Pages: 3 - 3

5. Albendazole

   Newsletter Article 31 January 2013 Pages: 3 - 3

6. Aluminium hydroxide

   Newsletter Article 31 January 2013 Pages: 3 - 4

7. Antacids

   Newsletter Article 31 January 2013 Pages: 4 - 4

8. Antipsychotics

   Newsletter Article 31 January 2013 Pages: 4 - 4

9. Caffeine

   Newsletter Article 31 January 2013 Pages: 4 - 4

10. Clobazam see Phenytoin interaction

    Newsletter Article 31 January 2013 Pages: 4 - 4

11. Cocaine see Tetracaine/epinephrine/cocaine

    Newsletter Article 31 January 2013 Pages: 4 - 4

12. Contrast media

    Newsletter Article 31 January 2013 Pages: 4 - 4

13. Diltiazem

    Newsletter Article 31 January 2013 Pages: 4 - 4

14. Enalapril

    Newsletter Article 31 January 2013 Pages: 4 - 4

15. Epinephrine see Tetracaine/epinephrine/cocaine

    Newsletter Article 31 January 2013 Pages: 5 - 5

16. Fenoverine/tienilic acid

    Newsletter Article 31 January 2013 Pages: 5 - 5

17. Flecainide

    Newsletter Article 31 January 2013 Pages: 5 - 5

18. Fluorouracil

    Newsletter Article 31 January 2013 Pages: 5 - 5

19. Fluoxetine

    Newsletter Article 31 January 2013 Pages: 5 - 5

20. Granulocyte-macrophage colony-stimulating factor

    Newsletter Article 31 January 2013 Pages: 5 - 5

21. Growth hormone human

    Newsletter Article 31 January 2013 Pages: 5 - 5

22. Heparin

    Newsletter Article 31 January 2013 Pages: 5 - 6

23. Hepatitis B vaccine

    Newsletter Article 31 January 2013 Pages: 6 - 6

24. Interleukin 2

    Newsletter Article 31 January 2013 Pages: 6 - 6

25. Lisinopril

    Newsletter Article 31 January 2013 Pages: 6 - 6

26. Methylprednisolone

    Newsletter Article 31 January 2013 Pages: 6 - 6

27. Muzolimine

    Newsletter Article 31 January 2013 Pages: 6 - 6

28. Nafcillin see Warfarin interaction

    Newsletter Article 31 January 2013 Pages: 6 - 6

29. Omeprazole

    Newsletter Article 31 January 2013 Pages: 6 - 6

30. Phenprocoumon

    Newsletter Article 31 January 2013 Pages: 7 - 7

31. Phenytoin

    Newsletter Article 31 January 2013 Pages: 7 - 7

32. Phenytoin see Warfarin interaction

    Newsletter Article 31 January 2013 Pages: 7 - 7

33. Phenytoin interaction

    Newsletter Article 31 January 2013 Pages: 7 - 7

34. Prochlorperazine

    Newsletter Article 31 January 2013 Pages: 7 - 7

35. Streptokinase/urokinase

    Newsletter Article 31 January 2013 Pages: 7 - 8

36. Tetracaine/epinephrine/cocaine

    Newsletter Article 31 January 2013 Pages: 8 - 8

37. Tienilic acid see Fenoverine/tienilic acid

    Newsletter Article 31 January 2013 Pages: 8 - 8

38. Trifluoperazine

    Newsletter Article 31 January 2013 Pages: 8 - 8

39. Urokinase see Streptokinase/urokinase

    Newsletter Article 31 January 2013 Pages: 8 - 8

40. Warfarin interaction

    Newsletter Article 31 January 2013 Pages: 8 - 8

41. Zidovudine

    Newsletter Article 31 January 2013 Pages: 8 - 8